Business · 07/03/2016

FDA Releases Guidance on Environmental Assessments for Drugs with Hormone Activity

The Food and Drug Administration (FDA) has published a guidance document to help pharmaceutical companies determine if they need to conduct environmental assessments for drugs that may have estrogenic, androgenic, or thyroid activity, and to clarify the process for submitting categorical exclusions.